{"rows":[{"id":3410,"title":"PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEG","authors":"Tyls F, Michaela Viktorinova T, Prokopcova D, Korcak J, Androvicova R, Brunovsky M, Horacek J.","journal":"The international journal of neuropsychopharmacology","publication_date":"2016-05-27","publication_year":2016,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC5616440","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Clinical Trial","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:53","last_checked":"2026-08-09 08:15:34","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC5616440","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC5616440","source_url":"https://europepmc.org/article/PMC/PMC5616440","doi":"","pmid":"","publication_date":"2016-05-27","importer_version":"2.1.3","text_redistributed":false}},{"id":3408,"title":"PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers - preliminary report","authors":"Palenicek T, Tyls F, Viktorinova M, Prokopcova D, Korcak J, Androvicova R, Brunovsky M, Horacek J.","journal":"The international journal of neuropsychopharmacology","publication_date":"2016-05-27","publication_year":2016,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC5616436","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Healthy Volunteers","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:52","last_checked":"2026-08-09 08:15:34","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC5616436","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC5616436","source_url":"https://europepmc.org/article/PMC/PMC5616436","doi":"","pmid":"","publication_date":"2016-05-27","importer_version":"2.1.3","text_redistributed":false}},{"id":3344,"title":"PSILOCYBIN MITIGATES BEHAVIORAL DESPAIR AND COGNITIVE RECOGNITION IMPAIRMENTS BY REGULATING THE HYPOTHALAMIC- PITUITARY-ADRENAL (HPA) AXIS VIA THE BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) SIGNALING PATHWAY MEDIATED BY THE ENDOCANNABINOID SYSTEM (ECS)","authors":"*Zitong Wang, Yanbo Zhang, Xin-Min Li","journal":"The international journal of neuropsychopharmacology","publication_date":"2025-02-01","publication_year":2025,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC11814968","substance_tags":"psilocybin","topic_tags":"Mechanism of Action","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:51","last_checked":"2026-08-09 08:15:26","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC11814968","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC11814968","source_url":"https://europepmc.org/article/PMC/PMC11814968","doi":"","pmid":"","publication_date":"2025-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3302,"title":"ANXIOLYTIC- AND PROCOGNITIVE-LIKE EFFECTS OF A30-DAY CHRONIC TREATMENT WITH A LOW NON-PSYCHEDELIC DOSE OF PSILOCYBIN IN C57BL/6J MICE","authors":"Sofia Nasini, Sara Tidei, Benedetta Barzon, Sara De Martin, Marco Banzato, Andrea Mattarei, Franco Folli, Marco Pappagallo, Paolo L Manfredi, *Stefano Comai","journal":"The international journal of neuropsychopharmacology","publication_date":"2025-02-01","publication_year":2025,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC11815219","substance_tags":"psilocybin","topic_tags":"Animal Study","study_type":"Animal Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:50","last_checked":"2026-08-09 08:15:21","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC11815219","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC11815219","source_url":"https://europepmc.org/article/PMC/PMC11815219","doi":"","pmid":"","publication_date":"2025-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3292,"title":"BEHAVIORAL PHENOTYPING AND METABOLOMIC COMPARISON OF CHEMICALLY SYNTHESIZED PSILOCYBIN AND PSYCHEDELIC MUSHROOM EXTRACT IN A ZEBRAFISH DEPRESSION MODEL","authors":"*Leonard Lerer, Katherine Spear, Jeet Varia, Cecily Keim, Alex Buko, Karin Blakolmer, Bernard Lerer","journal":"The international journal of neuropsychopharmacology","publication_date":"2025-02-01","publication_year":2025,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC11815225","substance_tags":"psilocybin","topic_tags":"Depression,Metabolomics","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:50","last_checked":"2026-08-09 08:15:19","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC11815225","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC11815225","source_url":"https://europepmc.org/article/PMC/PMC11815225","doi":"","pmid":"","publication_date":"2025-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3291,"title":"ASSOCIATIONS BETWEEN ESCITALOPRAM AND PSILOCYBIN THERAPY AND BRAIN RESTING-STATE FUNCTIONAL CONNECTIVITY IN MAJOR DEPRESSIVE DISORDER","authors":"Rebecca Harding, Natalie Ertl, Rayyan Zafar","journal":"The international journal of neuropsychopharmacology","publication_date":"2025-02-01","publication_year":2025,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC11814992","substance_tags":"psilocybin","topic_tags":"Depression","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:50","last_checked":"2026-08-09 08:57:51","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC11814992","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC11814992","source_url":"https://europepmc.org/article/PMC/PMC11814992","doi":"","pmid":"","publication_date":"2025-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3270,"title":"519. PSILOCYBIN ASSISTED PSYCHOTHERAPY FOR OBSESSIVE COMPULSIVE DISORDER, BODY DYSMORPHIC DISORDER, AND ANOREXIA NERVOSA: STUDY PROTOCOL","authors":"N Acevdo, D Castle, S Rossell","journal":"The international journal of neuropsychopharmacology","publication_date":"2025-08-01","publication_year":2025,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC12359785","substance_tags":"psilocybin","topic_tags":"Eating Disorders","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:49","last_checked":"2026-08-09 08:15:17","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC12359785","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359785","source_url":"https://europepmc.org/article/PMC/PMC12359785","doi":"","pmid":"","publication_date":"2025-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3265,"title":"631. PSILOCYBIN AND KETANSERIN VS RTMS IN TREATMENT-RESISTANT DEPRESSION: ENHANCING TOLERABILITY BY MITIGATING PSYCHEDELIC EFFECTS","authors":"G Martinotti, C Cavallotto, G D'Andrea, A D'Attilio, G Mammarella, F Zoratto, M Pettorruso","journal":"The international journal of neuropsychopharmacology","publication_date":"2025-08-01","publication_year":2025,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC12359594","substance_tags":"psilocybin","topic_tags":"Depression,Treatment-Resistant Depression,Safety","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:49","last_checked":"2026-08-09 08:15:16","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC12359594","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359594","source_url":"https://europepmc.org/article/PMC/PMC12359594","doi":"","pmid":"","publication_date":"2025-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3264,"title":"317. PSILOCYBIN DOES NOT INDUCE CONDITIONED PLACE PREFERENCE, BUT MODIFIES BEHAVIORAL PATTERNS IN SPRAGUE-DAWLEY RATS","authors":"V Bruno, B Richardson, M Lopez-Canul, T Marcourakis, R Camarini, G Gobbi","journal":"The international journal of neuropsychopharmacology","publication_date":"2025-08-01","publication_year":2025,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC12359800","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:49","last_checked":"2026-08-09 08:57:51","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC12359800","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359800","source_url":"https://europepmc.org/article/PMC/PMC12359800","doi":"","pmid":"","publication_date":"2025-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3263,"title":"164. PSILOCYBIN DURING THE POSTPARTUM PERIOD INDUCES LONG-LASTING ADVERSE EFFECTS IN BOTH MOTHERS AND OFFSPRING","authors":"C Hatzipantelis, D Olson, D Stolzenberg","journal":"The international journal of neuropsychopharmacology","publication_date":"2025-08-01","publication_year":2025,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC12359495","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:49","last_checked":"2026-08-09 08:15:16","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC12359495","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359495","source_url":"https://europepmc.org/article/PMC/PMC12359495","doi":"","pmid":"","publication_date":"2025-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3257,"title":"620. IDENTIFICATION OF BLOOD BIOMARKERS OF PSILOCYBIN-ASSISTED THERAPY TREATMENT RESPONSE FOR GENERALISED ANXIETY DISORDER","authors":"A Gibbons, P Liknaitzky, S Sundram","journal":"The international journal of neuropsychopharmacology","publication_date":"2025-08-01","publication_year":2025,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC12359512","substance_tags":"psilocybin","topic_tags":"Anxiety,Biomarkers","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:49","last_checked":"2026-08-09 08:57:51","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC12359512","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359512","source_url":"https://europepmc.org/article/PMC/PMC12359512","doi":"","pmid":"","publication_date":"2025-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3256,"title":"426. THE MGLUR2/3 ANTAGONIST ENHANCES THE BEHAVIORAL AND CELLULAR ANTIDEPRESSANT-LIKE EFFECTS OF PSILOCYBIN AND SCOPOLAMINE","authors":"Y Babii, C-S Barbara, D Bederska-Łojewska, B Szewczyk, A Pałucha-Poniewiera, K Gołembiowska, A Pilc","journal":"The international journal of neuropsychopharmacology","publication_date":"2025-08-01","publication_year":2025,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC12359596","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:49","last_checked":"2026-08-09 08:57:51","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC12359596","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359596","source_url":"https://europepmc.org/article/PMC/PMC12359596","doi":"","pmid":"","publication_date":"2025-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3246,"title":"EFFECT OF ACUTE PSILOCYBIN ON THERMAL AND NEUROPATHIC PAIN IN RODENTS","authors":"Martha Lopez Canul, Vivienne Nguyen, Antonio Inserra, Ella Nield, Hannah Billings, Gabriella Gobbi","journal":"The international journal of neuropsychopharmacology","publication_date":"2025-02-01","publication_year":2025,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC11814656","substance_tags":"psilocybin","topic_tags":"Chronic Pain","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:49","last_checked":"2026-08-09 08:57:51","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC11814656","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC11814656","source_url":"https://europepmc.org/article/PMC/PMC11814656","doi":"","pmid":"","publication_date":"2025-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3237,"title":"694. INVESTIGATING THE POTENTIAL OF PSILOCYBIN FOR COMPULSIVE EATING IN A RAT MODEL OF BINGE EATING","authors":"N Fabila, N P Manaph, V Rudkowsky, D Sketriene, Y Li, R Anversa, L Walker, A Reichelt, C Foldi, M Menden, R Brown","journal":"The international journal of neuropsychopharmacology","publication_date":"2025-08-01","publication_year":2025,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC12359587","substance_tags":"psilocybin","topic_tags":"Animal Study","study_type":"Animal Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:49","last_checked":"2026-08-09 08:15:13","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC12359587","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359587","source_url":"https://europepmc.org/article/PMC/PMC12359587","doi":"","pmid":"","publication_date":"2025-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3236,"title":"363. DIFFERENTIAL EFFECTS OF PSILOCYBIN AND LISURIDE ON SEROTONIN AND DOPAMINE NEURONAL ACTIVITY AND BEHAVIOR","authors":"B Richardson, M Pileggi, T Prud’Homme, D Wan-Yan-Chan, I Shareghi-Ghahreman, S Nasini, V Bruno, T Strand, M Leyton, N Sonenberg, D De Gregorio, J Sprouse, F Bambico, G Gobbi","journal":"The international journal of neuropsychopharmacology","publication_date":"2025-08-01","publication_year":2025,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC12359530","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:48","last_checked":"2026-08-09 08:15:13","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC12359530","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359530","source_url":"https://europepmc.org/article/PMC/PMC12359530","doi":"","pmid":"","publication_date":"2025-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3235,"title":"229. PSILOCYBIN WITH PSYCHOTHERAPEUTIC SUPPORT FOR TREATMENT-RESISTANT DEPRESSION: A PILOT CLINICAL TRIAL","authors":"S Meikle, O Carter, P Liknaitzky, L Johansen, R Iyer, N Strauss, M Williams, D Castle, S Rossell","journal":"The international journal of neuropsychopharmacology","publication_date":"2025-08-01","publication_year":2025,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC12359778","substance_tags":"psilocybin","topic_tags":"Depression,Clinical Trial,Treatment-Resistant Depression","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:48","last_checked":"2026-08-09 08:57:51","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC12359778","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359778","source_url":"https://europepmc.org/article/PMC/PMC12359778","doi":"","pmid":"","publication_date":"2025-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3225,"title":"205. SYNERGISTIC BEHAVIORAL AND NEUROPLASTIC EFFECTS OF PSILOCYBIN-NMDAR MODULATOR ADMINISTRATION","authors":"B Lerer, T Ben Tal, I Pogodin, A Botvinnik, T Lifschytz, U Heresco-Levy","journal":"The international journal of neuropsychopharmacology","publication_date":"2025-08-01","publication_year":2025,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC12359736","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:48","last_checked":"2026-08-09 08:15:12","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC12359736","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359736","source_url":"https://europepmc.org/article/PMC/PMC12359736","doi":"","pmid":"","publication_date":"2025-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3224,"title":"564. TOWARD AN UNDERSTANDING OF THE THERAPEUTICALLY RELEVANT MECHANISMS OF PSILOCYBIN FOR ANOREXIA NERVOSA","authors":"C Foldi","journal":"The international journal of neuropsychopharmacology","publication_date":"2025-08-01","publication_year":2025,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC12359394","substance_tags":"psilocybin","topic_tags":"Eating Disorders,Mechanism of Action","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:48","last_checked":"2026-08-09 08:57:51","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC12359394","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359394","source_url":"https://europepmc.org/article/PMC/PMC12359394","doi":"","pmid":"","publication_date":"2025-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3215,"title":"476. ACUTE AND CHRONIC PSILOCYBIN IN MOUSE MODELS OF PSYCHIATRIC DISORDERS","authors":"T Renoir, J Gattuso, B Bezcioglu, G Kong, M Ekwudo, C Wilson, N Kleditzsch, A Kamal, J Hendey, C Gubert, A Hannan","journal":"The international journal of neuropsychopharmacology","publication_date":"2025-08-01","publication_year":2025,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC12359791","substance_tags":"psilocybin","topic_tags":"Animal Study","study_type":"Animal Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:48","last_checked":"2026-08-09 08:57:51","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC12359791","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359791","source_url":"https://europepmc.org/article/PMC/PMC12359791","doi":"","pmid":"","publication_date":"2025-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3213,"title":"597. ARE SIDE EFFECTS NECESSARY FOR ANTIDEPRESSIVE TREATMENT: THE PSILOCYBIN EXPERIENCE","authors":"S Kasper","journal":"The international journal of neuropsychopharmacology","publication_date":"2025-08-01","publication_year":2025,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC12359505","substance_tags":"psilocybin","topic_tags":"Depression,Adverse Events","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:48","last_checked":"2026-08-09 08:57:51","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC12359505","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC12359505","source_url":"https://europepmc.org/article/PMC/PMC12359505","doi":"","pmid":"","publication_date":"2025-08-01","importer_version":"2.1.3","text_redistributed":false}}],"total":32,"page":1,"per_page":20,"pages":2,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"The international journal of neuropsychopharmacology","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}